BackAziyo Biologics Overview

Aziyo Biologics Current Cash

Track Aziyo Biologics's current cash ($20M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$19.90M
134.07% YoYΔ $11.40M vs prior year quarter

Peer trimmed avg / median

Loading

Aziyo Biologics Current Cash History

Loading

Aziyo Biologics vs. peers: Current Cash Comparison

Loading

Aziyo Biologics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aziyo Biologics (AZYO) FAQ

As of the most recent data (June 2026), AZYO shows a current cash of $20M. That compares with $8.5M in the prior-year period — up 134.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AZYO's current cash is now $20M (was $8.5M) — a 134.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Aziyo Biologics is outperforming or lagging.

Tracking AZYO's current cash over time shows whether Aziyo Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $20M That compares with $8.5M in the prior-year period — up 134.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Aziyo Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $20M) with ownership activity and broader fundamentals.

Aziyo Biologics's current cash is $20M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.